VK2809   Click here for help

GtoPdb Ligand ID: 12768

Synonyms: compound 22c [PMID: 18975928] | MB-07811 | MB07811 | VK-2809
Compound class: Synthetic organic
Comment: VK2809 (MB07811) was a first-in-class, liver-targeting, thyroid hormone receptor-β agonist prodrug that was intended to lower serum cholesterol and triglycerides as a novel treament for primary hypercholesterolemia and non-alcoholic fatty liver disease [2-5].
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species

VK2809 is commercially available from our sponsors

2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES CC(C)C1=CC(=CC=C1O)CC2=C(C)C=C(C=C2C)OC[P@@]3(=O)OCC[C@@H](C4=CC=CC(=C4)Cl)O3
Isomeric SMILES CC(C)C1=C(O)C=CC(CC2=C(C)C=C(OC[P@@]3(=O)OCC[C@H](O3)C4=CC(Cl)=CC=C4)C=C2C)=C1
InChI InChI=1S/C28H32ClO5P/c1-18(2)25-14-21(8-9-27(25)30)15-26-19(3)12-24(13-20(26)4)32-17-35(31)33-11-10-28(34-35)22-6-5-7-23(29)16-22/h5-9,12-14,16,18,28,30H,10-11,15,17H2,1-4H3/t28-,35+/m0/s1
InChI Key LGGPZDRLTDGYSQ-JADSYQMUSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
No information available.
Summary of Clinical Use Click here for help
VK2809 is under clinical investigations in study volunteers with non-alcoholic steatohepatitis (NASH) or primary hypercholesterolemia and non-alcoholic fatty liver disease (NAFLD).
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT00879112 Study of MB07811 in Subjects With Hypercholesterolemia Phase 2 Interventional Ligand Pharmaceuticals This trial was terminated before any participants were recruited.
NCT04173065 A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH Phase 2 Interventional Viking Therapeutics, Inc.
NCT02927184 Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease Phase 2 Interventional Viking Therapeutics, Inc.